Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

Publikation

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

Wissenschaftlicher Artikel/Review - 01.11.2001

Bonneterre J, Arimidex Writing Committee, Steinberg M, Webster A, Sahmoud T, von Euler M, Thürlimann Beat, Robertson J F, Nabholtz J M, Buzdar A, Investigators Committee Members

Bonneterre, J

Buzdar, A

Nabholtz, J M

Robertson, J F

Thürlimann, Beat

259

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

Bonneterre, J

Buzdar, A

Nabholtz, J M

Robertson, J F

Thürlimann, Beat

von Euler, M

Sahmoud, T

Webster, A

Steinberg, M

Arimidex Writing Committee,

Investigators Committee Members,